NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,787.30+₹26.30 (+1.49%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 12.68% below the high.
Loading market information…
NSE · UNIHEALTH.NS · INR
Stock price
Quote as of Oct 30, 2026, 05:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Unihealth Hospitals Ltd.’s quoted price sits in the upper half of its reported 52-week range, 32.32% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Unihealth Hospitals Ltd. is a healthcare service provider operating a network of multi-specialty hospitals, medical centers, and diagnostic facilities with a primary focus on the African healthcare market and growing presence in India. The company offers a range of tertiary care services, including surgical interventions, specialized medical treatments across various disciplines such as cardiology, oncology, nephrology, orthopedics, and neurology, as well as dialysis services. It operates facilities like UMC Victoria Hospital in Uganda and UMC Zhahir Hospital in Tanzania, along with medical centers and a newly launched multi-specialty hospital in Navi Mumbai, India, with further expansion plans in India. Unihealth Hospitals Ltd. also provides healthcare consultancy and project management services for establishing healthcare infrastructure in India and African countries. Additionally, the company is involved in the export and distribution of pharmaceuticals, medical consumables, nutraceuticals, and medical equipment from India to several African nations. A key component of their business is facilitating medical value travel, assisting patients from African countries in accessing advanced medical care in India, and fostering "Reverse Medical Tourism" for specialized services within Africa. The company aims to provide accessible and high-quality healthcare by combining Indian clinical expertise with localized partnerships.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹1,787.30+₹26.30 (+1.49%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 12.68% below the high.
₹9,789.00+₹125.00 (+1.29%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.41% below the high.
₹4,627.00+₹47.00 (+1.03%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.87% below the high.
₹2,346.30+₹102.30 (+4.56%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.08% below the high.
₹1,227.20+₹42.80 (+3.61%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.4% below the high.
₹8,270.00+₹70.00 (+0.85%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.83% below the high.
₹680.30-₹1.45 (-0.21%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
₹1,350.00+₹5.00 (+0.37%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.59% below the high.
